Toulmin, S. A., Bhadiadra, C., Paris, A. J., Lin, J. H., Katzen, J., Basil, M. C., . . . Eisenlohr, L. C. (2021). Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation. Nature Portfolio.
Cita Chicago Style (17a ed.)Toulmin, Sushila A., Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy Katzen, Maria C. Basil, Edward E. Morrisey, G. Scott Worthen, y Laurence C. Eisenlohr. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.
Cita MLA (8a ed.)Toulmin, Sushila A., et al. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.